CytomX Therapeutics, Inc.
SEC Filing List
CTMX CIK: 0001501989
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Cytomx Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/03/2026 | |
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |||
| SCHEDULE 13G/A | KLEINBERG KAPLAN WOLFF & COHEN P C /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| 8-K | Current report filing | Cytomx Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Cytomx Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| DEF 14A | Definitive proxy statements | Cytomx Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/30/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Cytomx Therapeutics, Inc. | Broadridge Financial Solutions, Inc. /fa | 04/30/2026 | |
| No record found. | |||||
| Load More | |||||
